Allogenic Adipose Tissue-Derived Mesenchymal Progenitor Cells for the Treatment of Knee Osteoarthritis
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Knee Osteoarthritis
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Double (Participant, Investigator)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 40 years and 75 years
- Gender
- Both males and females
Description
A Multicenter, Randomized, Double-blind, Controlled Phase II Trial of Allogenic Adipose Tissue-Derived Mesenchymal Progenitor Cells (AlloJoin®) Therapy for Knee Osteoarthritis. This is a multicenter, randomized, double-blinded, phase II clinical trial. Subjects who are with a clinical diagnosis of k...
A Multicenter, Randomized, Double-blind, Controlled Phase II Trial of Allogenic Adipose Tissue-Derived Mesenchymal Progenitor Cells (AlloJoin®) Therapy for Knee Osteoarthritis. This is a multicenter, randomized, double-blinded, phase II clinical trial. Subjects who are with a clinical diagnosis of knee osteoarthritis cartilage defects and will be randomly distributed 1:1:1 to different group after signing the ICF and screening tests. Each group was treated for two cycles. The patients were followed up to 48 weeks after the first treatment.
Tracking Information
- NCT #
- NCT04208646
- Collaborators
- RenJi Hospital
- Shanghai 6th People's Hospital
- Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
- Second Affiliated Hospital, School of Medicine, Zhejiang University
- China-Japan Friendship Hospital
- Huashan Hospital
- Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
- Investigators
- Principal Investigator: Chunde Bao Shanghai Jiaotong University School of Medicine, Renji Hospital Principal Investigator: Changqing Zhang Shanghai 6th People's Hospital Principal Investigator: Guochun Wang China-Japan Friendship Hospital Principal Investigator: Chengqing Yi Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine Principal Investigator: Shigui Yan Second Affiliated Hospital, School of Medicine, Zhejiang University Principal Investigator: Weiguo Wan Huashan Hospital Principal Investigator: Jinwu Wang Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Get Well Soon